Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL055493-04
Application #
6330892
Study Section
Special Emphasis Panel (ZRG1-SSS-T (01))
Program Officer
Applebaum-Bowden, Deborah
Project Start
1997-08-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
4
Fiscal Year
2001
Total Cost
$356,025
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Parolini, Cinzia; Chiesa, Giulia; Gong, Elaine et al. (2005) Apolipoprotein A-I and the molecular variant apoA-I(Milano): evaluation of the antiatherogenic effects in knock-in mouse model. Atherosclerosis 183:222-9
Natarajan, Pradeep; Forte, Trudy M; Chu, Berbie et al. (2004) Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1. J Biol Chem 279:24044-52
Parolini, Cinzia; Chiesa, Giulia; Zhu, Yiwen et al. (2003) Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion. J Biol Chem 278:4740-6
Beckstead, Jennifer A; Oda, Michael N; Martin, Dale D O et al. (2003) Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry 42:9416-23
Jia, Zhen; Natarajan, Pradeep; Forte, Trudy M et al. (2002) Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-I(Milano). Biochem Biophys Res Commun 297:206-13
Bielicki, John K; Oda, Michael N (2002) Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry 41:2089-96
Oda, M N; Bielicki, J K; Berger, T et al. (2001) Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity. Biochemistry 40:1710-8